Global clinical trial management system market report published by Accurize Market Research forecast that the global market is expected to reach $4 billion by 2025; growing at a CAGR of 14% from 2017 to 2025. By geography, the Asia Pacific and Europe are expected to grow at a CAGR of 15.3% and 14.2%, respectively, during the forecast period.

Report Sample:

https://www.accurizemarketresearch.com/report/clinical-trial-management-system-market/sample-request

Rising R&D investments and an increasing number of clinical trials across the globe to drive the growth of the market

Rising R&D investments and increasing the number of clinical trials fuel the demand for the global clinical trial management system market. Moreover, increasing product launches and the need for accurate data also boost the growth of the market.

Market Segmentation

The global clinical trial management system market has been bifurcated on the basis of component, type, mode of delivery, end-user, and geography. By component, it is further segmented into software and services. Type can be segmented into an enterprise clinical trial management system and site clinical trial management system. Furthermore, the mode of the delivery segment is segmented into web-based (on-demand), licensed enterprise (on-premise) and cloud-based (SaaS) segments. The end-user segment can be segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, medical device companies, and others.

By geography, the market is segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). The U.S., Canada, and Mexico are covered under North America wherein Europe covers Russia, the U.K., Germany, France, Italy and the Rest of Europe. Asia-Pacific covers China, India, Japan, South Korea and Rest of Asia Pacific. The rest of the World (RoW) covers South America, the Middle East, and Africa.

Customize Report:

https://www.accurizemarketresearch.com/report/clinical-trial-management-system-market/ask-for-customization

“Cloud-based (SaaS) accounted for the largest market share in the mode of the delivery segment", says Accurize

By mode of delivery, cloud-based (SaaS) accounted for the largest market share, followed by web-based (on-demand).

The pharmaceutical and biopharmaceutical sector dominated the end-user segment with maximum share in 2017.

“Software accounted for the largest market share in the component segment", says Accurize

By component, Software dominated the component segment with the largest market share in 2017.

“North America dominated the global market with the highest market share over the forecast period", says Accurize

In 2017, North America dominated the market with a 60% share followed by Europe with 27%. In terms of growth, Asia-Pacific is anticipated to attain the fastest CAGR during the forecast period, owing to improving infrastructure, increasing the outsourcing of clinical trials, and increasing the need for digitalization.

Top players in the market

The key market players include Oracle Corporation, Medidata Solutions Inc, Parexel International Corporation, DATATRAK International, Inc., Guger Technologies Inc., Forte Research Systems, Mednet Solutions, Bioclinica, BioOptronics, Inc., and ICON plc, among others.